T. Rowe Price Associates’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2M | Sell |
|
|||||
|
2025
Q1 | $23.9M | Sell |
|
|||||
|
2024
Q4 | $23M | Sell |
|
|||||
|
2024
Q3 | $20.8M | Sell |
|
|||||
|
2024
Q2 | $18.6M | Sell |
|
|||||
|
2024
Q1 | $18.6M | Sell |
|
|||||
|
2023
Q4 | $27.5M | Sell |
|
|||||
|
2023
Q3 | $24.7M | Sell |
|
|||||
|
2023
Q2 | $84.5M | Buy |
|
|||||
|
2023
Q1 | $83.2M | Buy |
|
|||||
|
2022
Q4 | $49M | Sell |
|
|||||
|
2022
Q3 | $73.7M | Sell |
|
|||||
|
2022
Q2 | $65.7M | Sell |
|
|||||
|
2022
Q1 | $64.1M | Sell |
|
|||||
|
2021
Q4 | $83.9M | Buy |
|
|||||
|
2021
Q3 | $78.3M | Sell |
|
|||||
|
2021
Q2 | $89.3M | Sell |
|
|||||
|
2021
Q1 | $102M | Sell |
|
|||||
|
2020
Q4 | $135M | Sell |
|
|||||
|
2020
Q3 | $106M | Sell |
|
|||||
|
2020
Q2 | $125M | Buy |
|
|||||
|
2020
Q1 | $91.6M | Sell |
|
|||||
|
2019
Q4 | $194M | Buy |
|
|||||
|
2019
Q3 | $127M | Sell |
|
|||||
|
2019
Q2 | $174M | Buy |
|
|||||
|
2019
Q1 | $133M | Buy |
|
|||||
|
2018
Q4 | $94.5M | Buy |
|
|||||
|
2018
Q3 | $117M | Buy |
|
|||||
|
2018
Q2 | $22.5M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $272K | Buy |
|